You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CPD

Narcolepsy and Idiopathic Hypersomnia: Unraveling the Connection Between Orexin/Hypocretin and Patient Struggles

  • Authors: Yves Dauvilliers, MD, PhD; Lucie Barateau, MD, PhD; Thomas E. Scammell, MD; Giuseppe Plazzi, MD, PhD
  • CPD Released: 11/10/2023
  • Valid for credit through: 11/10/2024, 11:59 PM EST
Start Activity

  • Credits Available

    Non-US Physicians - maximum of 1.00 CPD

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This activity is intended for an international audience of non-US neurologists, psychiatrists, and pulmonologists.

The goal of this activity is for learners to be better able to describe the role of the orexin system in sleep/wakefulness and the patient burden when this system is disrupted.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Role of orexin/hypocretin in maintaining normal wake and sleep states
    • Patient burden of narcolepsy type 1 (NT1)
    • Patient burden of narcolepsy type 2 (NT2) and idiopathic hypersomnia


Disclosures

WebMD Global requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies.


Moderator

  • Yves Dauvilliers, MD, PhD

    Professor of Physiology
    Director, Sleep-Wake Disorders Unit, Department of Neurology
    Gui De Chauliac Hospital
    Director, National Reference Centre for Orphan Diseases, Narcolepsy, Idiopathic Hypersomnia, and Kleine-Levin Syndrome
    Institute of Neurosciences of Montpellier
    University of Montpellier INSERM
    Montpellier, France

    Disclosures

    Yves Dauvilliers, MD, PhD, has the following relevant financial relationships:
    Consultant or advisor for: Avadel Pharmaceutical PLC; Bioprojet; Idorsia Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Orexia; Takeda
    Research funding from: Bioprojet; Jazz Pharmaceuticals, Inc.; Orexia; Takeda

Panelists

  • Lucie Barateau, MD, PhD

    Associate Professor of Physiology
    Sleep-Wake Disorders Unit, Department of Neurology
    Gui De Chauliac Hospital
    National Reference Centre for Orphan Diseases, Narcolepsy, Idiopathic Hypersomnia, and Kleine-Levin Syndrome
    Institute of Neurosciences of Montpellier
    University of Montpellier INSERM
    Montpellier, France

    Disclosures

    Lucie Barateau, MD, PhD, has no relevant financial relationships.

  • Thomas E. Scammell, MD

    Professor of Neurology
    Division of Sleep Medicine
    Harvard Medical School
    Boston, Massachusetts, United States

    Disclosures

    Thomas E. Scammell, MD, has the following relevant financial relationships:
    Consultant or advisor for: Avadel Pharmaceuticals PLC; Axsome Therapeutics, Inc.; ConSynance; Eisai Inc.; Harmony Biosciences, LLC; Jazz Pharmaceuticals, Inc.; Merck; Synchrony Healthcare; Takeda; Vertex Pharmaceuticals Incorporated; Woolsey Pharmaceuticals
    Research funding from: Harmony Biosciences, LLC; Jazz Pharmaceuticals, Inc.; Takeda

  • Giuseppe Plazzi, MD, PhD

    Neurologist
    Head of the Sleep Center
    IRCCS Istituto delle Scienze Neurologiche di Bologna
    Bologna, Italy
    Chair of Child Neurology
    University of Modena and Reggio Emilia
    Modena, Italy

    Disclosures

    Giuseppe Plazzi, MD, PhD, has the following relevant financial relationships:
    Consultant or advisor for: Bioprojet; Idorsia Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Orexia; Takeda

Editor

  • Katherine Carpenter, PhD

    Medical Education Director, WebMD Global, LLC 

    Disclosures

    Katherine Carpenter, PhD, has the following relevant financial relationships:
    Consultant or advisor for: Eisai, Inc. (former)

Compliance Reviewer

  • Leigh Schmidt, MSN, RN, CNE, CHCP

    Associate Director, Accreditation and Compliance

    Disclosures

    Leigh Schmidt, MSN, RN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements

    For Physicians

  • The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 1.0 continuing professional development credits (CPD).

    Contact WebMD Global

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information about your eligibility to claim credit, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must complete the activity online during the credit eligibility period that is noted on the title page.

Follow these steps to claim a credit certificate for completing this activity:

  1. Read the information provided on the title page regarding the target audience, learning objectives, and author disclosures, read and study the activity content and then complete the post-test questions. If you earn a passing score on the post-test and we have determined based on your registration profile that you may be eligible to claim CPD credit for completing this activity, we will issue you a CPD credit certificate.
  2. Once your CPD credit certificate has been issued, you may view and print the certificate from your CME/CE Tracker. CPD credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of the Medscape Education homepage.

We encourage you to complete an Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

CPD

Narcolepsy and Idiopathic Hypersomnia: Unraveling the Connection Between Orexin/Hypocretin and Patient Struggles

Authors: Yves Dauvilliers, MD, PhD; Lucie Barateau, MD, PhD; Thomas E. Scammell, MD; Giuseppe Plazzi, MD, PhDFaculty and Disclosures

CPD Released: 11/10/2023

Valid for credit through: 11/10/2024, 11:59 PM EST

processing....

Learning Feedback Questions

Please answer the questions below to self-assess your knowledge. Answering these questions again after the activity will allow you to see what you learned.

  • Print